| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028913 Conformationally stabilized cell adhesion peptides |
| 03/07/2002 | US20020028912 Polyethylene glycol derivative modifying granulocyte colony stimulating factor activity |
| 03/07/2002 | US20020028785 Telomerase resistance; anticancer agents |
| 03/07/2002 | US20020028773 Genetic engineering |
| 03/07/2002 | US20020028767 Glucose dependent release of insulin from glucose sensing insulin derivatives |
| 03/07/2002 | US20020028764 Administering somatomedins |
| 03/07/2002 | US20020028762 Medicament and method for treating renal disease |
| 03/07/2002 | US20020028514 Recombinant AAV vector-based transduction system and use of same |
| 03/07/2002 | US20020028513 P element derived vector and methods for its use |
| 03/07/2002 | US20020028508 Novel genes encoding proteins having prognostic, diagnostic, preventive , therapeutic and other uses |
| 03/07/2002 | US20020028498 Genetically engineered nucleotide sequences for use in the treatment of viral disease and tumors |
| 03/07/2002 | US20020028494 57256 and 58289, novel human transporters and uses thereof |
| 03/07/2002 | US20020028487 Polypeptide; for use in detection of cell cycle modulators |
| 03/07/2002 | US20020028486 Adjusting affinity of immunoglobulins; generate expression vector, insert preferential sequences, express vector in cells, recover preferential immunoglobulin |
| 03/07/2002 | US20020028485 Polypeptide; for use in diagnosis and treatment of cancer, lung, cardiovascular, inflammation, kidney, pain, psychological and nervous system disorders |
| 03/07/2002 | US20020028484 Expression vector for use in the treatment and prevention of viral diseases |
| 03/07/2002 | US20020028483 Novel potassium channel molecules and uses therefor |
| 03/07/2002 | US20020028482 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of autoimune disease, arthritis, infections, myasthenia gravis, asthma and cancer |
| 03/07/2002 | US20020028481 Expression using fused genes providing for protein product |
| 03/07/2002 | US20020028473 Components of dense microspheres derived from mammalian brain tissue detectable in cerebrospinal fluid |
| 03/07/2002 | US20020028470 Human zona pellucida protein 3 and uses thereof |
| 03/07/2002 | US20020028465 Genetic engineering; anticancer agents |
| 03/07/2002 | US20020028462 Alpha-2-macroglobulin isotype diagnostic test for Alzheimer's disease |
| 03/07/2002 | US20020028453 Methods and compositions for producing morphogen analogs |
| 03/07/2002 | US20020028449 26 Human secreted proteins |
| 03/07/2002 | US20020028211 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 03/07/2002 | US20020028210 Vaccine composition comprising helicobacter pylori flagellin polypeptide |
| 03/07/2002 | US20020028208 Nucleic acid encoding feline cd86 |
| 03/07/2002 | US20020028207 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/07/2002 | US20020028206 Method for enhancing immunogenicity of antigens |
| 03/07/2002 | US20020028205 May be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1; absorber to prevent a hyperacute rejection of a xenotransplant |
| 03/07/2002 | US20020028203 T cell inhibitory receptor compositions and uses thereof |
| 03/07/2002 | US20020028202 Common gamma chain blocking agents |
| 03/07/2002 | US20020028200 Enhancing the production of antibodies which recognize and bind to FimH of uropathogenic Type-I-fimbriated Escherichia coli, but not to FimH of non-uropathogenic Type I- fimbriated Escherichia coli. |
| 03/07/2002 | DE10123071A1 Neue für das ccpA2-Gen kodierende Nukleotidsequenzen New coding for the ccpA2 gene nucleotide sequences |
| 03/07/2002 | DE10110053A1 Neue für das oxyR-Gen kodierende Nukleotidsequenzen New coding for the oxyR gene nucleotide sequences |
| 03/07/2002 | DE10110052A1 Neue für das ccpA1-Gen kodierende Nukleotidsequenzen New coding for the ccpA1 gene nucleotide sequences |
| 03/07/2002 | DE10042051A1 Neue für das cstA-Gen kodierende Nukleotidsequenzen New coding for the cstA gene nucleotide sequences |
| 03/07/2002 | DE10041842A1 Genetisch verändertes, nicht-menschliches Säugetier, das ein zusätzliches induzierbares Regulator-Gen enthält Genetically modified, non-human mammal, containing an additional inducible regulatory gene |
| 03/07/2002 | DE10041560A1 New peptide from the alpha1 adrenergic receptor, useful for diagnosis and treatment of psoriasis, and also for raising specific antibodies |
| 03/07/2002 | DE10038111A1 New G protein coupled receptors, useful for diagnosis, treatment and prevention of skin and wound-healing disorders, also related nucleic acid and antibodies |
| 03/07/2002 | CA2705366A1 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2457165A1 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 03/07/2002 | CA2457162A1 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | CA2424052A1 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | CA2421122A1 Novel nucleic acids and polypeptides |
| 03/07/2002 | CA2421055A1 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | CA2420944A1 Inhibition of cmv infection and dissemination |
| 03/07/2002 | CA2420902A1 18 human secreted proteins |
| 03/07/2002 | CA2420852A1 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/07/2002 | CA2420765A1 Anti-angiogenic peptides |
| 03/07/2002 | CA2420659A1 Genes expressed in the cell cycle |
| 03/07/2002 | CA2420652A1 Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | CA2420593A1 Tumor necrosis factor receptors 6.alpha. and 6.beta. |
| 03/07/2002 | CA2420392A1 17 human secreted proteins |
| 03/07/2002 | CA2420320A1 7 human secreted proteins |
| 03/07/2002 | CA2420277A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | CA2420105A1 Human kinases |
| 03/07/2002 | CA2420062A1 Erbb4 antagonists |
| 03/07/2002 | CA2419860A1 Method for screening highly active proteases and inhibitors |
| 03/07/2002 | CA2419851A1 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation |
| 03/07/2002 | CA2419661A1 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | CA2419342A1 G-protein coupled receptors |
| 03/07/2002 | CA2417136A1 Proteins related to schizophrenia and uses thereof |
| 03/06/2002 | EP1184463A1 Method of detecting protein-protein interaction |
| 03/06/2002 | EP1184459A2 Manipulation of gene copy number in Bordetella |
| 03/06/2002 | EP1184457A1 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/06/2002 | EP1184456A2 Haplotypes of the AGTR1 gene |
| 03/06/2002 | EP1184454A2 Nav2 channel gene-deficient non-human animals |
| 03/06/2002 | EP1184393A1 Process for the purification of EPI-HNE proteins |
| 03/06/2002 | EP1184392A1 Stabilized denatured lipoprotein and process for producing the same |
| 03/06/2002 | EP1184391A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1184390A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1183534A2 Identification of novel mechanisms of drug resistance |
| 03/06/2002 | EP1183392A1 Diagnosis, prognosis and treatment of cancer related to the barx2 gene |
| 03/06/2002 | EP1183391A2 Interaction of the cyclic-amp-specific phosphodiesterase pde4d5 with rack1 |
| 03/06/2002 | EP1183386A1 Tm4sf receptors |
| 03/06/2002 | EP1183382A2 Method for selecting improved vectors |
| 03/06/2002 | EP1183381A2 Synthetic gene for expressing active retroviral protein in eukaryotes |
| 03/06/2002 | EP1183375A2 Tapetum-specific promoters |
| 03/06/2002 | EP1183374A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof |
| 03/06/2002 | EP1183368A2 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung |
| 03/06/2002 | EP1183367A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy |
| 03/06/2002 | EP1183366A2 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS |
| 03/06/2002 | EP1183365A1 Bacteriocin, preparation and use thereof |
| 03/06/2002 | EP1183364A1 Groel muteins with improved stability |
| 03/06/2002 | EP1183363A2 Methods for regulating protein conformation using molecular chaperones |
| 03/06/2002 | EP1183362A1 Il-1 eta dna and polypeptides |
| 03/06/2002 | EP1183361A1 Gene therapy of pulmonary disease |
| 03/06/2002 | EP1183360A2 Modified cytokine for its stabilisation |
| 03/06/2002 | EP1183359A2 Nucleic acids and proteins with interferon-beta activity |
| 03/06/2002 | EP1183358A1 Targeted angiogenesis |
| 03/06/2002 | EP1183357A2 Vascular endothelial growth factor dimers |
| 03/06/2002 | EP1183356A2 Gustatory receptors in drosophila |
| 03/06/2002 | EP1183355A1 T-bet compositions and methods of use thereof |
| 03/06/2002 | EP1183354A2 Methods of reducing factor viii clearance and compositions therefor |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |